companydata.dkcompanydata.dk

PharmaSphere Consulting ApS: Financial statements 2025

CVR: 36696222

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

PharmaSphere Consulting ApS (CVR 36696222) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 2,479,823 and a net result of DKK 321,621 compared with DKK 688,490 the year before. That is a decrease of 5.7% compared with the year before. Equity in the 2025 report amounted to DKK 466,582. The solvency ratio was 52.9%. The company had 2 employees in the financial year.

Gross Profit
DKK 2,479,823
Profit/Loss
DKK 321,621
Equity
DKK 466,582
Total Assets
DKK 881,352
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-2.5 mio.322 t.467 t.2
2024-2.6 mio.688 t.745 t.1
2023-1.7 mio.320 t.386 t.1
2022-916 t.266 t.317 t.1
2021-138 t.88 t.138 t.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is PharmaSphere Consulting ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

PharmaSphere Consulting ApS: The 2024 annual report is outMar 11, 2025

PharmaSphere Consulting ApS has published its annual report for 2024. Gross profit came to DKK 2,629,520, and the net result was DKK 688,490.

About PharmaSphere Consulting ApS

PharmaSphere Consulting ApS is a Danish company of the type Anpartsselskab based in Ballerup, founded in 2015. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. The management consists of Søren Graves Truelsen. The company is owned by STruelsen-Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 2,479,823 and a net result of DKK 321,621 compared with DKK 688,490 the year before. Equity in the 2025 report amounted to DKK 466,582.

Source: annual report 2025, Danish Business Authority